Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 1991Biochemical JournalOpen Access

Characterization of Sp-5,6-dichloro-1-β-d-ribofuranosylbenzimidazole- 3′,5′-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMårten SandbergOslo University HospitalEBElke ButtUniversity of Southern CaliforniaCNChristiané NolteMax Delbrück Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sandberg et al. (1991) studied this question.

synapsesocial.com/papers/6a70d9b735aa2c282ce22df8https://doi.org/10.1042/bj2790521
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 15,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro1989 · 239 citations
  2. 2Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues.1977 · 267 citations
  3. 3Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture1980 · 302 citations